FDA Approves First HIV Prevention Shot

A recent Interesting Engineering article contained good news in the fight against the HIV epidemic. Last Monday, the FDA announced its approval of the first injectable medication for pre-exposure prevention (aka PrEP) against HIV. The drug is called Apretude, and it was developed by ViiV Healthcare, which is majority-owned by GlaxoSmithKline. It is comparable to other HIV prevention pills such as Truvada and Descovy, which reduce HIV transmission risk by 99% when taken daily.